Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease. (Record no. 24761878)

MARC details
000 -LEADER
fixed length control field 01456 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517024025.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201603s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1096-1186
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.phrs.2015.03.010
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Golpich, Mojtaba
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20160301
245 00 - TITLE STATEMENT
Title Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Pharmacological research
Date of publication, distribution, etc. Jul 2015
300 ## - PHYSICAL DESCRIPTION
Extent 16-26 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiparkinson Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glycogen Synthase Kinase 3
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glycogen Synthase Kinase 3 beta
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Inflammation
General subdivision physiopathology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Parkinson Disease
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Signal Transduction
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Amini, Elham
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hemmati, Fatemeh
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ibrahim, Norlinah Mohamed
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rahmani, Behrouz
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mohamed, Zahurin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Raymond, Azman Ali
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dargahi, Leila
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ghasemi, Rasoul
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ahmadiani, Abolhassan
773 0# - HOST ITEM ENTRY
Title Pharmacological research
Related parts vol. 97
-- p. 16-26
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.phrs.2015.03.010">https://doi.org/10.1016/j.phrs.2015.03.010</a>
Public note Available from publisher's website

No items available.